HY RU EN
Asset 3

Loading

End of content No more pages to load

Your search did not match any articles

Japanese Drug Firm Seeks to Invest in Armenia

RoA Deputy Prime Minister Armen Gevorgyan today met with representatives of the Japanese Minophagen Pharmaceutical Industries Co. Minophagen VP Tushitsuku Sato said that the objective of the delegation's visit to Armenia was not only to introduce its product line of drugs to Armenia but to also set up a production unit with the RoA National Academy of Sciences Chemical Institute. Minophagen, established in 1938, is world renowned for its line of drugs used to combat chronic hepatitis B and C Deputy PM Gevorgyan stated that the Armenian government places great importance on new innovations that can assist in the nation's development, especially if it deals with people's health. He noted that Armenia is one of the post-Soviet countries where huge scientific potential exists and thus, the conditions ensuring a successful implementation of the company's plans in Armenia are also present. Also present at the meeting were Academician Fadeh Sargsyan, an advisor to the RoA Prime Minister, and Academician Rafayel Melik-Ohanjanyan, who presented a brief overview of Armenian-Japanese scientific ties.

Write a comment

Hetq does not publish comments containing offensive language or personal attacks. Please criticize content, not people. And please use "real" names, not monikers. Thanks again for following Hetq.
If you found a typo you can notify us by selecting the text area and pressing CTRL+Enter